KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) FCF Payout Ratio (2020 - 2025)

Evolent Health has reported FCF Payout Ratio over the past 6 years, most recently at 0.28 for Q3 2025.

  • Quarterly results put FCF Payout Ratio at 0.28 for Q3 2025, down 32.09% from a year ago — trailing twelve months through Dec 2025 was 2.34 (up 171.4% YoY), and the annual figure for FY2025 was 2.34, up 171.4%.
  • FCF Payout Ratio for Q3 2025 was 0.28 at Evolent Health, up from 0.12 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for EVH hit a ceiling of 3.36 in Q2 2022 and a floor of 11.59 in Q1 2024.
  • Median FCF Payout Ratio over the past 5 years was 0.04 (2021), compared with a mean of 0.73.
  • Biggest five-year swings in FCF Payout Ratio: surged 7809.87% in 2022 and later crashed 5307.49% in 2024.
  • Evolent Health's FCF Payout Ratio stood at 0.04 in 2021, then surged by 7809.87% to 3.36 in 2022, then crashed by 98.16% to 0.06 in 2023, then plummeted by 339.58% to 0.15 in 2024, then soared by 289.74% to 0.28 in 2025.
  • The last three reported values for FCF Payout Ratio were 0.28 (Q3 2025), 0.12 (Q2 2025), and 1.14 (Q1 2025) per Business Quant data.